Gainers
Mirati Therapeutics (NASDAQ: MRTX) shares are trading higher after the company announced it received Breakthrough Therapy Designation from the FDA for patients with advanced non-small cell lung cancer harboring the KRAS G12C mutation.
Shares of Nike (NYSE:NKE) moved higher in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share rose 282.35% year over year to $0.93, which beat the estimate of $0.51.
Nike (NYSE:NKE) reported quarterly earnings of $0.93 per share which beat the analyst consensus estimate of $0.51 by 82.35 percent. This is a 282.35 percent increase over losses of $(0.51) per share from the same period